Skip to main content
Erschienen in: Reactions Weekly 1/2019

01.10.2019 | Case report

Denosumab

Hypocalcaemia: 8 case reports

Erschienen in: Reactions Weekly | Ausgabe 1/2019

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Huang T-H, et al. Efficacy and safety of denosumab therapy for low bone mineral density in childhood cancer survivors: A report of preliminary experience. Pediatric Blood and Cancer 66: e27927, No. 10, Oct 2019. Available from: URL: http://doi.org/10.1002/pbc.27927 - Taiwan Huang T-H, et al. Efficacy and safety of denosumab therapy for low bone mineral density in childhood cancer survivors: A report of preliminary experience. Pediatric Blood and Cancer 66: e27927, No. 10, Oct 2019. Available from: URL: http://​doi.​org/​10.​1002/​pbc.​27927 - Taiwan
Metadaten
Titel
Denosumab
Hypocalcaemia: 8 case reports
Publikationsdatum
01.10.2019
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2019
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-019-68884-7

Weitere Artikel der Ausgabe 1/2019

Reactions Weekly 1/2019 Zur Ausgabe

Case report

Alemtuzumab

Case report

Cyclophosphamide

Case report

Fentanyl abuse